Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,940 public trials 1,514 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Active, Not Recruiting

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

NCT05409066

Conditions
Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • The University of Arizona Cancer Center - North Campus /ID# 228862 Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 227198 Little Rock, Arkansas, United States
  • Alta Bates Summit Medical Center for Research /ID# 229428 Berkeley, California, United States
  • Beverly Hills Cancer Center /ID# 231535 Beverly Hills, California, United States
View all 273 locations
View Trial Details
Active, Not Recruiting

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

NCT04464226

Conditions
Cancer, Neoplasms
Locations
  • Urology Centers of Alabama, PC - Homewood Homewood, Alabama, United States
  • Ironwood Cancer and Research Centers - Chandler I Chandler, Arizona, United States
  • Tower Urology Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto Palo Alto, California, United States
View all 335 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

NCT05283720

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations
  • The University of Arizona Cancer Center - North Campus /ID# 242219 Tucson, Arizona, United States
  • Yale University School of Medicine /ID# 242089 New Haven, Connecticut, United States
  • Christiana Care Health Service /ID# 242301 Newark, Delaware, United States
  • Tampa General Hospital /ID# 246748 Tampa, Florida, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

Durvalumab and Tremelimumab for Pediatric Malignancies

NCT03837899

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +5 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New Hyde Park, New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies

NCT04606381

Conditions
Neoplasms
Locations
  • Cedars Sinai Medical Center West Hollywood, California, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Langone Health at NYC University, NYU School of Medicine New York, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)

NCT05112965

Conditions
Neoplasms
Locations
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Union Hospital of Tongji Medical College, Dept. of Cancer Center Wuhan, Hubei, China
  • Cancer Hospital of Shandong First Medical University Jinan, Shandong, China
View all 17 locations
View Trial Details

Related conditions